8-K 1 stjude062306_8k.htm FORM 8-K DATED JUNE 1, 2006 St. Jude Medical, Inc. Form 8-K dated June 1, 2006


 
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 1, 2006

ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)

Minnesota 0-8672 41-1276891
(State or other jurisdiction
of incorporation)		 (Commission
File Number)		 (IRS Employer
Identification No.)


One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 


Item 7.01    Regulation FD Disclosure.

St. Jude Medical, Inc. (the “Company”) has completed the repurchase of shares of its common stock under its previously announced $700 million share repurchase authorization. The following table provides information about the shares repurchased by the Company under the share repurchase authorization:

Period Total Number of
Shares Purchased 		Average Price
Paid Per Share 		Total Number of
Shares Purchased as
a Part of Publicly
Announced Program 		Approximate Dollar
Value of Shares that
May Yet be Purchased
Under the Program (1)
4/02/06 – 4/29/06        4,847,000     $  39.52      4,847,000     $508,455,000  
4/30/06 – 5/26/06    13,732,390    $  37.03    13,732,390    $                  0  
     18,579,390     $  37.68    18,579,390    $                  0  

(1)

On April 19, 2006, the Company announced that its Board of Directors had authorized a new share repurchase program of up to $700 million of the Company’s outstanding common stock. On April 21, 2006, the Company began making share repurchases through transactions in the open market in accordance with applicable securities laws. The repurchase plan entered into by the Company under the repurchase authorization terminated on May 26, 2006, the date on which no further purchases were authorized under the plan.










SIGNATURE

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ST. JUDE MEDICAL, INC.
 
 
Date:   June 1, 2006
By:    /s/ Kevin T. O’Malley
Kevin T. O’Malley
 Vice President and
General Counsel